Intended laboratory context
Illustrative applications
- Analytical method development
- In-vitro laboratory investigation
- Identity comparison
- Research protocol development
Lyophilized Peptides
BPC-157
BPC-157 research peptide
A synthetic 15-residue peptide research material identified by the sequence GEPPPGKPADDAGLV.
CatalogBPC-PW
ManufacturerRemetide
PurityProposed ≥99% by RP-HPLC; lot result controls
PackResearch pack · supplied amount shown on product record
Price range: $55.00 through $85.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
For laboratory research use only. Not for human or veterinary use.
BPC-157$55.00 – $85.00Price range: $55.00 through $85.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Technical information
Chemical & material record
Presented in a scientific-catalog format so the material can be evaluated by identity, form and documentation before purchase.
- Identity
- BPC-157 acetate
- Synonyms
- BPC-157 research peptide
- CAS number
- 1628202-19-6
- Molecular formula
- C62H98N16O22 · X(C2H4O2)
- Formula weight
- 1,419.5 Da, excluding variable acetate contribution
- Sequence / identity note
- GEPPPGKPADDAGLV
- Manufacturer
- Remetide
- Manufacturing role
- Custom peptide synthesis and manufacture
- Form
- Lyophilized, non-sterile research material
- Purity specification
- Proposed ≥99% by RP-HPLC; lot result controls
- Storage
- -20°C, dry and protected from light; follow lot documentation
- Pack size
- Research pack · supplied amount shown on product record
- Catalog number
- BPC-PW
Product description
Published context, clearly separated from lot claims.
A technical catalog should make the chemical record, relevant experimental literature and product-specific documentation independently reviewable.
BPC-157 is a pentadecapeptide described in published literature as a fragment associated with body protection compound. Research has examined the peptide in cell-migration, cytoskeletal and multiple non-clinical model systems.
In primary rat tendon fibroblasts, 2 µg/mL BPC-157 was reported to increase cell migration and F-actin formation. Other cited studies evaluated inflammatory and gastric-lesion endpoints in rodents. These findings are preclinical and do not establish human safety or efficacy.
Selected published findings
- Increased migration and F-actin formation in primary rat tendon fibroblasts in a published in-vitro study.
- Was evaluated in rodent models involving inflammatory and gastric-lesion endpoints.
References and product citations 2
- Chang, C.H., Tsai, W.C., Lin, M.S., et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology 110(3), 774–780 (2011).
- Sikiric, P., Seiwerth, S., Rucman, R., et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Neuropharmacology 14(8), 818–829 (2016).
Literature interpretation: This summary describes published experimental literature and is not a lot specification, clinical claim, use instruction or representation that the supplied research material will reproduce a published result. This record intentionally excludes dosing, administration, clinical outcomes, patient eligibility and therapeutic comparisons.
Proposed package
Documentation
- PDFCertificate of AnalysisSample
- PDFHPLC chromatogramSample
- PDFMass-spectrometry summarySample
- PDFHandling statementSample
For laboratory research workflows only. Not for administration to humans or animals and not supplied with dosing or reconstitution guidance.
Need a current record?
Documentation before decision-making.
Reference BPC-PW and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model